We are live on ! Find out more
GWPH

GW Pharmaceuticals Plc American Depositary Shares
GWPH

Delisted

GWPH was delisted on the 4th of May, 2021.

Back to rankings

1 hedge funds and large institutions have $3K invested in GW Pharmaceuticals Plc American Depositary Shares in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 294 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% less funds holding

Funds holding: 297 → 1 (-296)

100% less funds holding in top 10

Funds holding in top 10: 21 → 0 (-21)

100% less capital invested

Capital invested by funds: $5.23B → $3K (-$5.23B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 294

Holders
1
Holders Change
-296
Holders Change %
-99.66%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
-21
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
294
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
PCM
Pentwater Capital Management
Florida
-$456M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$325M
3
HI
HBK Investments
Texas
-$292M
4
FCM
Farallon Capital Management
California
-$277M
5
GCL
Glazer Capital LLC
New York
-$212M
Name Holding Trade Value Shares
Change 		Change in
Stake
RIL
126
Rothschild Investment LLC
Illinois
– -$1.62M -7,455 Closed
Vontobel Holding
127
Vontobel Holding
Switzerland
– -$1.56M -7,200 Closed
MWNA
128
Marshall Wace North America
New York
– -$1.55M -7,154 Closed
Franklin Resources
129
Franklin Resources
California
– -$1.5M -6,901 Closed
MTCM
130
Mint Tower Capital Management
Netherlands
– -$1.5M -6,900 Closed
Cambridge Investment Research Advisors
131
Cambridge Investment Research Advisors
Iowa
– -$1.49M -6,850 Closed
RE
132
RBC Europe
United Kingdom
– -$1.45M -6,664 Closed
GT
133
Greenleaf Trust
Michigan
– -$1.42M -6,558 Closed
HSBC Holdings
134
HSBC Holdings
United Kingdom
– -$1.35M -6,225 Closed
FCM
135
Firsthand Capital Management
California
– -$1.3M -6,000 Closed
Arrowstreet Capital
136
Arrowstreet Capital
Massachusetts
– -$1.24M -5,700 Closed
RJA
137
Raymond James & Associates
Florida
– -$1.21M -5,570 Closed
LSA
138
Leonteq Securities AG
Switzerland
– -$1.19M -5,475 Closed
VHAM
139
Van Hulzen Asset Management
California
– -$1.14M -5,240 Closed
Allianz Asset Management
140
Allianz Asset Management
Germany
– -$1.08M -5,000 Closed
CAPTRUST Financial Advisors
141
CAPTRUST Financial Advisors
North Carolina
– -$1.07M -4,936 Closed
FC
142
FORA Capital
Florida
– -$1.04M -4,817 Closed
SI
143
Stephens Inc
Arkansas
– -$1.04M -4,794 Closed
HighTower Advisors
144
HighTower Advisors
Illinois
– -$1.03M -4,766 Closed
CG
145
Cutler Group
California
– -$994K -4,586 Closed
Rockefeller Capital Management
146
Rockefeller Capital Management
New York
– -$992K -4,577 Closed
GCM
147
Gables Capital Management
Florida
– -$987K -4,550 Closed
EGM
148
Engineers Gate Manager
New York
– -$954K -4,400 Closed
ProShare Advisors
149
ProShare Advisors
Maryland
– -$907K -4,182 Closed
Creative Planning
150
Creative Planning
Kansas
– -$875K -4,034 Closed
4 5
6
7 8

GWPH Hedge Fund Activity: Q2 2021 in Review

1 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in GW Pharmaceuticals Plc American Depositary Shares (GWPH) for Q2 2021, worth a combined $3K — down 100% from $5.23B a quarter earlier.

Sellers outnumbered buyers: 294 funds closed out of GWPH and 0 opened new positions — a net loss of 294 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Pentwater Capital Management, exiting entirely with an estimated $456M sold.

  • 1 institutional investor held GW Pharmaceuticals Plc American Depositary Shares (GWPH) as of Q2 2021, down from 297 in Q1 2021.
  • Funds reported $3K of GW Pharmaceuticals Plc American Depositary Shares stock for Q2 2021, down 100% quarter-over-quarter.
  • 0 funds opened new GW Pharmaceuticals Plc American Depositary Shares positions in Q2 2021 and 294 closed out, a net change of -294 holders.
  • The largest GW Pharmaceuticals Plc American Depositary Shares seller in Q2 2021 was Pentwater Capital Management, an estimated $456M sold.

Based on aggregated 13F filings for Q2 2021.